Robert Burns Analyst Performance

Analyst at BTIG Research

Robert Burns is a stock analyst at BTIG Research focused in the medical sector, covering 51 publicly traded companies. Over the past year, Robert Burns has issued 142 stock ratings, including strong buy, buy, hold, and sell recommendations. While full access to Robert Burns' proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Robert Burns' coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
303 Last 6 Years
Buy Recommendations
91.06% 275 Buy Ratings
Companies Covered
51 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.3%1 ratings
Buy90.7%274 ratings
Hold8.6%26 ratings
Sell0.3%1 ratings

Out of 302 total stock ratings issued by Robert Burns at BTIG Research, the majority (90.7%) have been Buy recommendations, followed by 8.6% Hold, 0.3% Strong Buy, and 0.3% Sell.

Exchange Coverage

ExchangePercentageCount
NASDAQ
94.1% of companies on NASDAQ
48 companies
NYSE
3.9% of companies on NYSE
2 companies
NYSEAMERICAN
2.0% of companies on NYSEAMERICAN
1 company

Robert Burns, an analyst at BTIG Research, currently covers 51 companies listed on NASDAQ, NYSE and NYSEAMERICAN, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
48 companies
94.1%
Manufacturing
2 companies
3.9%
Financial Services
1 company
2.0%

Robert Burns of BTIG Research specializes in stock coverage within the Medical sector, with additional focus on Manufacturing and Financial Services companies.

Coverage Industries

IndustryPercentage
MED - BIOMED/GENE
38 companies
74.5%
MED - DRUGS
5 companies
9.8%
PHARMACEUTICAL PREPARATIONS
4 companies
7.8%
Miscellaneous
1 company
2.0%
SURGICAL & MEDICAL INSTRUMENTS
1 company
2.0%
INVESTMENT OFFICES
1 company
2.0%
MED PRODUCTS
1 company
2.0%

Robert Burns' Ratings History at BTIG Research

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Elicio Therapeutics, Inc. stock logo
ELTX
Elicio Therapeutics
6/15/2026Boost Price Target$14.85$23.00Buy
Nurix Therapeutics, Inc. stock logo
NRIX
Nurix Therapeutics
6/10/2026Reiterated Rating$15.64$32.00Buy
Tango Therapeutics, Inc. stock logo
TNGX
Tango Therapeutics
6/9/2026Boost Price Target$31.12$66.00Buy
ADC Therapeutics SA stock logo
ADCT
ADC Therapeutics
6/8/2026Downgrade$1.03Neutral
Oric Pharmaceuticals, Inc. stock logo
ORIC
Oric Pharmaceuticals
6/8/2026Reiterated Rating$7.50$25.00Buy
Fate Therapeutics, Inc. stock logo
FATE
Fate Therapeutics
6/8/2026Reiterated Rating$1.98$7.00Buy
Cullinan Therapeutics, Inc. stock logo
CGEM
Cullinan Therapeutics
6/8/2026Reiterated Rating$13.51$30.00Buy
Radiopharm Theranostics Limited - Sponsored ADR stock logo
RADX
Radiopharm Theranostics
6/4/2026Initiated Coverage$4.49$6.00Buy
Zymeworks Inc. stock logo
ZYME
Zymeworks
6/3/2026Reiterated Rating$24.11$46.00Buy
Aktis Oncology stock logo
AKTS
Aktis Oncology
6/2/2026Boost Price Target$19.81$35.00Buy
Revolution Medicines, Inc. stock logo
RVMD
Revolution Medicines
6/1/2026Boost Price Target$163.40$195.00Buy
Cardiff Oncology, Inc. stock logo
CRDF
Cardiff Oncology
6/1/2026Downgrade$1.90Neutral
Elicio Therapeutics, Inc. stock logo
ELTX
Elicio Therapeutics
5/28/2026Reiterated Rating$10.77$17.00Buy
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
5/28/2026Reiterated Rating$5.28$7.00Buy
Relay Therapeutics, Inc. stock logo
RLAY
Relay Therapeutics
5/26/2026Boost Price Target$13.53$28.00Buy
Immix Biopharma, Inc. stock logo
IMMX
Immix Biopharma
5/22/2026Boost Price Target$8.90$20.00Buy
Caribou Biosciences, Inc. stock logo
CRBU
Caribou Biosciences
5/11/2026Boost Price Target$1.94$11.00Buy
Exelixis, Inc. stock logo
EXEL
Exelixis
5/7/2026Boost Price Target$48.70$56.00Buy
Cogent Biosciences, Inc. stock logo
COGT
Cogent Biosciences
5/6/2026Boost Price Target$36.97$55.00Buy
Karyopharm Therapeutics Inc. stock logo
KPTI
Karyopharm Therapeutics
5/6/2026Boost Price Target$9.41$13.00Buy
ADC Therapeutics SA stock logo
ADCT
ADC Therapeutics
5/5/2026Reiterated Rating$3.64$8.00Buy
Nuvation Bio Inc. stock logo
NUVB
Nuvation Bio
5/5/2026Reiterated Rating$4.45$17.00Buy
Fate Therapeutics, Inc. stock logo
FATE
Fate Therapeutics
5/4/2026Boost Price Target$1.53$7.00Buy
Relay Therapeutics, Inc. stock logo
RLAY
Relay Therapeutics
4/29/2026Boost Price Target$13.03$25.00Buy
Black Diamond Therapeutics, Inc. stock logo
BDTX
Black Diamond Therapeutics
4/29/2026Boost Price Target$2.70$11.00Buy
Cullinan Therapeutics, Inc. stock logo
CGEM
Cullinan Therapeutics
4/28/2026Boost Price Target$12.85$30.00Buy
Prelude Therapeutics Incorporated stock logo
PRLD
Prelude Therapeutics
4/27/2026Boost Price Target$4.70$8.00Buy
Nurix Therapeutics, Inc. stock logo
NRIX
Nurix Therapeutics
4/27/2026Reiterated Rating$16.68$32.00Buy
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
4/27/2026Reiterated Rating$105.46$130.00Buy
Revolution Medicines, Inc. stock logo
RVMD
Revolution Medicines
4/22/2026Reiterated Rating$148.90Buy
Molecular Partners AG Sponsored ADR stock logo
MOLN
Molecular Partners
4/22/2026Reiterated Rating$4.49$13.00Buy
Allogene Therapeutics, Inc. stock logo
ALLO
Allogene Therapeutics
4/14/2026Boost Price Target$3.04$12.00Buy
Telix Pharmaceuticals Limited stock logo
TLX
Telix Pharmaceuticals
4/13/2026Reiterated Rating$10.54$20.00Buy
Replimune Group, Inc. stock logo
REPL
Replimune Group
4/13/2026Reiterated Rating$4.77Sell
Nurix Therapeutics, Inc. stock logo
NRIX
Nurix Therapeutics
4/10/2026Reiterated Rating$16.24$32.00Buy
Caribou Biosciences, Inc. stock logo
CRBU
Caribou Biosciences
4/7/2026Reiterated Rating$1.95$9.00Buy
Telix Pharmaceuticals Limited stock logo
TLX
Telix Pharmaceuticals
4/7/2026Reiterated Rating$9.09$20.00Buy
Oric Pharmaceuticals, Inc. stock logo
ORIC
Oric Pharmaceuticals
4/2/2026Reiterated Rating$7.47$25.00Buy
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
3/31/2026Lower Price Target$85.25$130.00Buy
Aktis Oncology stock logo
AKTS
Aktis Oncology
3/31/2026Boost Price Target$16.54$33.00Buy
SpaceX is offering you shares. Don't take them. (Ad)

SpaceX is reserving 30% of its IPO shares for retail investors through Robinhood, Fidelity, and Schwab. At a $1.75 trillion valuation and 266 times earnings, you're buying in at the most expensive IPO in history - right when institutions who got in at $800 billion need someone to sell to. Dylan Jovine has identified a small company in Musk's supply chain that builds the power infrastructure Colossus can't run without - and it's still trading at a fraction of its value.tc pixel

Skip the IPO trap and get the backdoor ticker for free
Bicara Therapeutics Inc. stock logo
BCAX
Bicara Therapeutics
3/31/2026Boost Price Target$19.04$42.00Buy
Immix Biopharma, Inc. stock logo
IMMX
Immix Biopharma
3/27/2026Boost Price Target$8.72$15.00Buy
Enliven Therapeutics, Inc. stock logo
ELVN
Enliven Therapeutics
3/26/2026Boost Price Target$35.53$56.00Buy
Karyopharm Therapeutics Inc. stock logo
KPTI
Karyopharm Therapeutics
3/25/2026Lower Price Target$5.44$8.00Buy
Nurix Therapeutics, Inc. stock logo
NRIX
Nurix Therapeutics
3/24/2026Reiterated Rating$14.69$32.00Buy
Adicet Bio, Inc. stock logo
ACET
Adicet Bio
3/23/2026Lower Price Target$6.92$27.00Buy
Relay Therapeutics, Inc. stock logo
RLAY
Relay Therapeutics
3/23/2026Boost Price Target$9.91$19.00Buy
ADC Therapeutics SA stock logo
ADCT
ADC Therapeutics
3/23/2026Boost Price Target$3.88$8.00Buy
Perspective Therapeutics, Inc. stock logo
CATX
Perspective Therapeutics
3/23/2026Boost Price Target$4.45$13.00Buy
OnKure Therapeutics, Inc. stock logo
OKUR
OnKure Therapeutics
3/16/2026Lower Price Target$3.78$27.00Buy
Molecular Partners AG Sponsored ADR stock logo
MOLN
Molecular Partners
3/16/2026Reiterated Rating$4.22$13.00Buy
Elicio Therapeutics, Inc. stock logo
ELTX
Elicio Therapeutics
3/13/2026Boost Price Target$10.90$17.00Buy
Oric Pharmaceuticals, Inc. stock logo
ORIC
Oric Pharmaceuticals
3/13/2026Reiterated Rating$11.76$25.00Buy
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
3/13/2026Reiterated Rating$4.05$7.00Buy
Aktis Oncology stock logo
AKTS
Aktis Oncology
3/9/2026Initiated Coverage$18.81$30.00Buy
ArriVent BioPharma, Inc. stock logo
AVBP
ArriVent BioPharma
3/6/2026Boost Price Target$25.25$44.00Buy
BridgeBio Oncology Therapeutics, Inc stock logo
BBOT
BridgeBio Oncology Therapeutics
3/6/2026Boost Price Target$9.89$29.00Buy
Tango Therapeutics, Inc. stock logo
TNGX
Tango Therapeutics
3/6/2026Boost Price Target$16.80$27.00Buy
Zymeworks Inc. stock logo
ZYME
Zymeworks
3/6/2026Boost Price Target$24.80$46.00Buy
Oric Pharmaceuticals, Inc. stock logo
ORIC
Oric Pharmaceuticals
2/24/2026Boost Price Target$12.46$25.00Buy
Karyopharm Therapeutics Inc. stock logo
KPTI
Karyopharm Therapeutics
2/18/2026Reiterated Rating$9.40$15.00Buy
Exelixis, Inc. stock logo
EXEL
Exelixis
2/12/2026Boost Price Target$42.94$54.00Buy
Exelixis, Inc. stock logo
EXEL
Exelixis
2/3/2026Reiterated Rating$42.81$52.00Buy
TuHURA Biosciences, Inc. stock logo
HURA
TuHURA Biosciences
2/3/2026Reiterated Rating$0.52$10.00Buy
Perspective Therapeutics, Inc. stock logo
CATX
Perspective Therapeutics
1/30/2026Boost Price Target$4.26$12.00Buy
Nurix Therapeutics, Inc. stock logo
NRIX
Nurix Therapeutics
1/29/2026Boost Price Target$17.87$32.00Buy
Cardiff Oncology, Inc. stock logo
CRDF
Cardiff Oncology
1/28/2026Reiterated Rating$2.00$10.00Buy
Molecular Partners AG Sponsored ADR stock logo
MOLN
Molecular Partners
1/27/2026Initiated Coverage$4.09$13.00Buy
Exelixis, Inc. stock logo
EXEL
Exelixis
1/27/2026Boost Price Target$43.61$52.00Buy
Molecular Partners AG Sponsored ADR stock logo
MOLN
Molecular Partners
1/27/2026Initiated Coverage$4.00$13.00Buy
Adicet Bio, Inc. stock logo
ACET
Adicet Bio
1/21/2026Reiterated Rating$7.90$50.00Buy
Telix Pharmaceuticals Limited stock logo
TLX
Telix Pharmaceuticals
1/21/2026Reiterated Rating$7.73$20.00Buy
Bicara Therapeutics Inc. stock logo
BCAX
Bicara Therapeutics
1/14/2026Reiterated Rating$17.53Buy
Nuvation Bio Inc. stock logo
NUVB
Nuvation Bio
1/12/2026Lower Price Target$8.03$17.00Buy
TuHURA Biosciences, Inc. stock logo
HURA
TuHURA Biosciences
1/9/2026Reiterated Rating$0.75$10.00Buy
Cullinan Therapeutics, Inc. stock logo
CGEM
Cullinan Therapeutics
1/8/2026Boost Price Target$10.71$27.00Buy
Exelixis, Inc. stock logo
EXEL
Exelixis
1/8/2026Boost Price Target$44.79$52.00Buy
Cogent Biosciences, Inc. stock logo
COGT
Cogent Biosciences
1/6/2026Boost Price Target$34.26$52.00Buy
Telix Pharmaceuticals Limited stock logo
TLX
Telix Pharmaceuticals
12/22/2025Reiterated Rating$7.80$20.00Buy
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
12/11/2025Reiterated Rating$96.00$140.00Buy
Nuvation Bio Inc. stock logo
NUVB
Nuvation Bio
12/11/2025Boost Price Target$7.90$18.00Buy
Nurix Therapeutics, Inc. stock logo
NRIX
Nurix Therapeutics
12/10/2025Boost Price Target$19.55$31.00Buy
Nuvation Bio Inc. stock logo
NUVB
Nuvation Bio
12/1/2025Reiterated Rating$8.05$10.00Buy
Cullinan Therapeutics, Inc. stock logo
CGEM
Cullinan Therapeutics
11/20/2025Boost Price Target$9.10$26.00Buy
Zymeworks Inc. stock logo
ZYME
Zymeworks
11/18/2025Boost Price Target$23.90$32.00Buy
Oric Pharmaceuticals, Inc. stock logo
ORIC
Oric Pharmaceuticals
11/14/2025Boost Price Target$13.08$23.00Buy
Cogent Biosciences, Inc. stock logo
COGT
Cogent Biosciences
11/13/2025Boost Price Target$35.26$50.00Buy
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
11/10/2025Boost Price Target$103.14$140.00Buy
Adicet Bio, Inc. stock logo
ACET
Adicet Bio
11/7/2025Boost Price Target$10.83$144.00Buy
Revolution Medicines, Inc. stock logo
RVMD
Revolution Medicines
11/6/2025Boost Price Target$59.34$73.00Buy
How to play the Biggest IPO in stock market history! (Ad)

SpaceX is eyeing a near-$2 trillion IPO valuation, and retail investors are already lining up - but early insiders and institutional holders have been sitting on positions for years and will exit the moment shares hit the market. Lance Ippolito has identified five stocks directly positioned to benefit from the SpaceX launch and the space investing wave it triggers, without the brutal IPO volatility. These picks carry none of the hype risk and all of the tailwind.tc pixel

Get all five tickers now, completely free
Caribou Biosciences, Inc. stock logo
CRBU
Caribou Biosciences
11/5/2025Boost Price Target$2.17$9.00Buy
Exelixis, Inc. stock logo
EXEL
Exelixis
11/5/2025Boost Price Target$39.06$49.00Buy
Cogent Biosciences, Inc. stock logo
COGT
Cogent Biosciences
11/4/2025Reiterated Rating$15.50$21.00Buy
MacroGenics, Inc. stock logo
MGNX
MacroGenics
11/3/2025Reiterated Rating$1.66$2.00Neutral
Fate Therapeutics, Inc. stock logo
FATE
Fate Therapeutics
10/31/2025Upgrade$1.29$5.00Buy
Zymeworks Inc. stock logo
ZYME
Zymeworks
10/27/2025Reiterated Rating$17.87Buy
Nurix Therapeutics, Inc. stock logo
NRIX
Nurix Therapeutics
10/27/2025Lower Price Target$11.98$28.00Buy
Replimune Group, Inc. stock logo
REPL
Replimune Group
10/27/2025Upgrade$8.80$12.00Buy
Repare Therapeutics Inc. stock logo
RPTX
Repare Therapeutics
10/27/2025Lower Price Target$1.90$3.00Buy
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
10/20/2025Set Price Target$5.74$7.00Buy
Nurix Therapeutics, Inc. stock logo
NRIX
Nurix Therapeutics
10/20/2025Reiterated Rating$9.84$33.00Buy
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
10/20/2025Initiated Coverage$5.86$7.00Buy
ADC Therapeutics SA stock logo
ADCT
ADC Therapeutics
10/16/2025Lower Price Target$4.24$7.00Buy
Nurix Therapeutics, Inc. stock logo
NRIX
Nurix Therapeutics
10/14/2025Lower Price Target$9.72$33.00Buy
Zymeworks Inc. stock logo
ZYME
Zymeworks
10/14/2025Set Price Target$18.11$26.00Buy
Karyopharm Therapeutics Inc. stock logo
KPTI
Karyopharm Therapeutics
10/13/2025Upgrade$5.50$15.00Buy
Perspective Therapeutics, Inc. stock logo
CATX
Perspective Therapeutics
10/3/2025Reiterated Rating$3.49$10.00Buy
Prelude Therapeutics Incorporated stock logo
PRLD
Prelude Therapeutics
9/23/2025Reiterated Rating$1.01$5.00Buy
Nuvation Bio Inc. stock logo
NUVB
Nuvation Bio
9/19/2025Reiterated Rating$3.16$10.00Buy
Perspective Therapeutics, Inc. stock logo
CATX
Perspective Therapeutics
9/19/2025Reiterated Rating$3.29$10.00Buy
Cullinan Therapeutics, Inc. stock logo
CGEM
Cullinan Therapeutics
9/12/2025Reiterated Rating$6.62$24.00Buy
Immix Biopharma, Inc. stock logo
IMMX
Immix Biopharma
9/12/2025Boost Price Target$2.22$8.00Buy
Telix Pharmaceuticals Limited stock logo
TLX
Telix Pharmaceuticals
9/10/2025Lower Price Target$9.66$20.00Buy
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
9/8/2025Reiterated Rating$112.46$136.00Buy
Replimune Group, Inc. stock logo
REPL
Replimune Group
9/8/2025Reiterated Rating$6.33Neutral
Relay Therapeutics, Inc. stock logo
RLAY
Relay Therapeutics
8/26/2025Lower Price Target$3.51$14.00Buy
OnKure Therapeutics, Inc. stock logo
OKUR
OnKure Therapeutics
8/26/2025Reiterated Rating$2.75$34.00Buy
Bicara Therapeutics Inc. stock logo
BCAX
Bicara Therapeutics
8/22/2025Lower Price Target$11.63$40.00Buy
Cullinan Therapeutics, Inc. stock logo
CGEM
Cullinan Therapeutics
8/21/2025Initiated Coverage$7.47$24.00Buy
Oric Pharmaceuticals, Inc. stock logo
ORIC
Oric Pharmaceuticals
8/14/2025Lower Price Target$9.83$19.00Buy
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
8/14/2025Lower Price Target$111.87$136.00Buy
ArriVent BioPharma, Inc. stock logo
AVBP
ArriVent BioPharma
8/12/2025Reiterated Rating$17.42$42.00Buy
Exelixis, Inc. stock logo
EXEL
Exelixis
8/12/2025Lower Price Target$37.41$46.00Buy
Black Diamond Therapeutics, Inc. stock logo
BDTX
Black Diamond Therapeutics
8/11/2025Lower Price Target$2.40$10.00Buy
Y-mAbs Therapeutics, Inc. stock logo
YMAB
Y-mAbs Therapeutics
8/6/2025Reiterated Rating$8.52$8.60Neutral
Cogent Biosciences, Inc. stock logo
COGT
Cogent Biosciences
8/6/2025Lower Price Target$11.36$21.00Buy
Cardiff Oncology, Inc. stock logo
CRDF
Cardiff Oncology
8/6/2025Lower Price Target$2.57$10.00Buy
Replimune Group, Inc. stock logo
REPL
Replimune Group
7/23/2025Downgrade$2.81Neutral
Adicet Bio, Inc. stock logo
ACET
Adicet Bio
7/23/2025Upgrade$12.03$64.00Strong-Buy
ArriVent BioPharma, Inc. stock logo
AVBP
ArriVent BioPharma
7/22/2025Reiterated Rating$21.55$40.00Buy
Elicio Therapeutics, Inc. stock logo
ELTX
Elicio Therapeutics
7/17/2025Boost Price Target$9.05$13.00Buy
Karyopharm Therapeutics Inc. stock logo
KPTI
Karyopharm Therapeutics
7/16/2025Downgrade$4.24Neutral
Nurix Therapeutics, Inc. stock logo
NRIX
Nurix Therapeutics
7/14/2025Lower Price Target$12.42$34.00Buy
Karyopharm Therapeutics Inc. stock logo
KPTI
Karyopharm Therapeutics
7/11/2025Initiated Coverage$5.00$27.00Buy
Cogent Biosciences, Inc. stock logo
COGT
Cogent Biosciences
7/8/2025Boost Price Target$9.33$22.00Buy
Telix Pharmaceuticals Limited stock logo
TLX
Telix Pharmaceuticals
7/3/2025Initiated Coverage$16.50$23.00Buy
Zymeworks Inc. stock logo
ZYME
Zymeworks
7/3/2025Reiterated Rating$12.89$13.00Neutral
Replimune Group, Inc. stock logo
REPL
Replimune Group
7/3/2025Reiterated Rating$9.55$22.00Buy
Enliven Therapeutics, Inc. stock logo
ELVN
Enliven Therapeutics
7/2/2025Boost Price Target$19.65$48.00Buy
Exelixis, Inc. stock logo
EXEL
Exelixis
6/30/2025Boost Price Target$43.67$53.00Buy
Tesla's robot factory goes live this summer (Ad)

On Tesla's Q1 2026 earnings call, Elon Musk confirmed Optimus robot production at the Fremont factory begins late July or August - with a target of one million units per year. One trader using a proprietary institutional capital flow system has identified five small companies he believes are directly in Tesla's Optimus supply chain. Two are trading under $4.tc pixel

See all five supply chain picks before the production window opens
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
6/25/2025Reiterated Rating$105.09$138.00Buy
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
6/16/2025Lower Price Target$106.57$138.00Buy
Exelixis, Inc. stock logo
EXEL
Exelixis
6/12/2025Reiterated Rating$41.43$47.00Buy
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
6/5/2025Boost Price Target$111.21$145.00Buy
Immix Biopharma, Inc. stock logo
IMMX
Immix Biopharma
6/4/2025Reiterated Rating$2.11$7.00Buy
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
5/22/2025Reiterated Rating$99.09$134.00Buy
Cogent Biosciences, Inc. stock logo
COGT
Cogent Biosciences
5/20/2025Lower Price Target$5.03$12.00Buy
Y-mAbs Therapeutics, Inc. stock logo
YMAB
Y-mAbs Therapeutics
5/19/2025Lower Price Target$4.10$11.00Buy
Enliven Therapeutics, Inc. stock logo
ELVN
Enliven Therapeutics
5/15/2025Boost Price Target$19.89$40.00Buy
Revolution Medicines, Inc. stock logo
RVMD
Revolution Medicines
5/14/2025Reiterated Rating$40.01$72.00Buy
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
5/14/2025Reiterated Rating$93.89$134.00Buy
ArriVent BioPharma, Inc. stock logo
AVBP
ArriVent BioPharma
5/14/2025Boost Price Target$18.76$40.00Buy
Cardiff Oncology, Inc. stock logo
CRDF
Cardiff Oncology
5/9/2025Boost Price Target$2.63$18.00Buy
Oric Pharmaceuticals, Inc. stock logo
ORIC
Oric Pharmaceuticals
5/5/2025Reiterated Rating$5.67$21.00Buy
Prelude Therapeutics Incorporated stock logo
PRLD
Prelude Therapeutics
5/5/2025Reiterated Rating$0.89$5.00Buy
SpringWorks Therapeutics stock logo
SWTX
SpringWorks Therapeutics
4/30/2025Reiterated Rating$46.24$47.00Neutral
Caribou Biosciences, Inc. stock logo
CRBU
Caribou Biosciences
4/28/2025Reiterated Rating$0.77$3.00Buy
Tango Therapeutics, Inc. stock logo
TNGX
Tango Therapeutics
4/14/2025Reiterated Rating$1.41$13.00Buy
Prelude Therapeutics Incorporated stock logo
PRLD
Prelude Therapeutics
4/8/2025Reiterated Rating$0.65$5.00Buy
Elicio Therapeutics, Inc. stock logo
ELTX
Elicio Therapeutics
4/2/2025Reiterated Rating$4.95$10.00Buy
Nurix Therapeutics, Inc. stock logo
NRIX
Nurix Therapeutics
4/2/2025Reiterated Rating$10.47$36.00Buy
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
4/1/2025Lower Price Target$91.06$145.00Buy
ADC Therapeutics SA stock logo
ADCT
ADC Therapeutics
3/31/2025Reiterated Rating$1.49$8.00Buy
Exelixis, Inc. stock logo
EXEL
Exelixis
3/27/2025Reiterated Rating$37.01$40.00Buy
MacroGenics, Inc. stock logo
MGNX
MacroGenics
3/25/2025Lower Price Target$1.96$2.00Neutral
Enliven Therapeutics, Inc. stock logo
ELVN
Enliven Therapeutics
3/21/2025Boost Price Target$20.92$39.00Buy
Y-mAbs Therapeutics, Inc. stock logo
YMAB
Y-mAbs Therapeutics
3/21/2025Lower Price Target$4.92$12.00Buy
PMV Pharmaceuticals, Inc. stock logo
PMVP
PMV Pharmaceuticals
3/20/2025Reiterated Rating$1.28$5.00Buy
Allogene Therapeutics, Inc. stock logo
ALLO
Allogene Therapeutics
3/19/2025Lower Price Target$1.69$8.00Buy
Caribou Biosciences, Inc. stock logo
CRBU
Caribou Biosciences
3/19/2025Reiterated Rating$0.95$9.00Buy
Black Diamond Therapeutics, Inc. stock logo
BDTX
Black Diamond Therapeutics
3/18/2025Boost Price Target$1.71$12.00Buy
Perspective Therapeutics, Inc. stock logo
CATX
Perspective Therapeutics
3/13/2025Initiated Coverage$2.66$10.00Buy
Nuvation Bio Inc. stock logo
NUVB
Nuvation Bio
3/10/2025Lower Price Target$2.03$10.00Buy
Zymeworks Inc. stock logo
ZYME
Zymeworks
3/10/2025Boost Price Target$11.09$13.00Neutral
Repare Therapeutics Inc. stock logo
RPTX
Repare Therapeutics
3/7/2025Lower Price Target$1.19$5.00Buy
Relay Therapeutics, Inc. stock logo
RLAY
Relay Therapeutics
3/7/2025Reiterated Rating$3.48$16.00Buy
ArriVent BioPharma, Inc. stock logo
AVBP
ArriVent BioPharma
3/7/2025Reiterated Rating$21.81$39.00Buy
TuHURA Biosciences, Inc. stock logo
HURA
TuHURA Biosciences
3/3/2025Initiated Coverage$2.41$13.00Buy
Revolution Medicines, Inc. stock logo
RVMD
Revolution Medicines
3/3/2025Boost Price Target$40.74$73.00Buy
Cardiff Oncology, Inc. stock logo
CRDF
Cardiff Oncology
2/28/2025Boost Price Target$4.06$17.00Buy
SpringWorks Therapeutics stock logo
SWTX
SpringWorks Therapeutics
2/21/2025Reiterated Rating$58.64$74.00Buy
Oric Pharmaceuticals, Inc. stock logo
ORIC
Oric Pharmaceuticals
2/21/2025Reiterated Rating$7.63$21.00Buy
Exelixis, Inc. stock logo
EXEL
Exelixis
2/13/2025Reiterated Rating$32.80$40.00Buy
Replimune Group, Inc. stock logo
REPL
Replimune Group
2/13/2025Boost Price Target$13.79$22.00Buy
SpringWorks Therapeutics stock logo
SWTX
SpringWorks Therapeutics
2/12/2025Reiterated Rating$55.13$74.00Buy
Oric Pharmaceuticals, Inc. stock logo
ORIC
Oric Pharmaceuticals
2/11/2025Reiterated Rating$11.23$21.00Buy
Immix Biopharma, Inc. stock logo
IMMX
Immix Biopharma
2/10/2025Reiterated Rating$2.01$7.00Buy
CARGO Therapeutics, Inc. stock logo
CRGX
CARGO Therapeutics
1/30/2025Downgrade$13.19Neutral
Nurix Therapeutics, Inc. stock logo
NRIX
Nurix Therapeutics
1/29/2025Boost Price Target$19.56$36.00Buy
Atara Biotherapeutics, Inc. stock logo
ATRA
Atara Biotherapeutics
1/28/2025Reiterated Rating$7.37Neutral
Stranded On The Flood Plains of History (Ad)

The petrodollar arrangement that Kissinger brokered in 1974 officially expired in June 2024. China has slashed U.S. Treasury holdings by 45% from peak, and central banks are swapping dollars for gold at the fastest pace since the Cold War. Porter Stansberry believes Trump is channeling more than $3 trillion toward securing the minerals, chips, and infrastructure that make AI possible - and companies at those chokepoints like Vertiv (up 500%), GE Vernova (up 700%), and Arista Networks (up 750%) are already moving. Porter's new briefing names one asset to buy today plus five stocks positioned at the narrowest chokepoints of what he calls the Silicon Dollar.tc pixel

Read Porter's full briefing and get the ticker names today
Exelixis, Inc. stock logo
EXEL
Exelixis
1/27/2025Reiterated Rating$32.38$40.00Buy
Nuvation Bio Inc. stock logo
NUVB
Nuvation Bio
1/23/2025Boost Price Target$2.65$11.00Buy
Atara Biotherapeutics, Inc. stock logo
ATRA
Atara Biotherapeutics
1/22/2025Reiterated Rating$6.05Neutral
ArriVent BioPharma, Inc. stock logo
AVBP
ArriVent BioPharma
1/22/2025Boost Price Target$25.31$39.00Buy
Replimune Group, Inc. stock logo
REPL
Replimune Group
1/22/2025Boost Price Target$11.85$21.00Buy
Cogent Biosciences, Inc. stock logo
COGT
Cogent Biosciences
1/14/2025Lower Price Target$7.57$14.00Buy
Relay Therapeutics, Inc. stock logo
RLAY
Relay Therapeutics
1/14/2025Reiterated Rating$4.78$16.00Buy
Y-mAbs Therapeutics, Inc. stock logo
YMAB
Y-mAbs Therapeutics
1/13/2025Reiterated Rating$6.89$22.00Buy
Oric Pharmaceuticals, Inc. stock logo
ORIC
Oric Pharmaceuticals
1/13/2025Reiterated Rating$8.29$21.00Buy
Exelixis, Inc. stock logo
EXEL
Exelixis
1/10/2025Boost Price Target$34.50$40.00Buy